CompoSecure, Inc. — Q3 2022 Form 10-Q
Filing identity: The supplied filing is for CompoSecure, Inc. (Nasdaq: CMPO), not an entity identified as GPGI, Inc. The unaudited quarter and nine-month periods ended September 30, 2022; comparisons are with the periods ended September 30, 2021 unless noted.
Business context
CompoSecure designs and manufactures premium metal and composite payment cards and also offers Arculus digital-asset security products. It reports as one operating segment. The 2021 comparison period predates the December 2021 business combination; the transaction was accounted for as a reverse recapitalization.
Financial results
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Net sales | $103.3m | $66.2m | $284.7m | $192.6m |
| Gross profit / margin | $61.8m / 60% | $36.1m / 55% | $169.4m / 59% | $105.6m / 55% |
| Operating income / margin | $25.6m / 25% | $21.6m / 33% | $90.0m / 32% | $72.2m / 37% |
| Net income | $21.9m | $18.7m | $109.5m | $63.4m |
| Net income attributable to CompoSecure, Inc. | $2.8m | $18.7m | $15.5m | $63.4m |
| Operating cash flow | Not stated for the quarter | $90.9m | $48.0m | |
| Capital expenditures | Not stated for the quarter | $7.2m | $3.9m | |
| Adjusted EBITDA (non-GAAP) | $32.7m | $24.6m | $105.6m | $81.2m |
Q3 sales rose 56%; nine-month sales rose 48%. Management attributed growth to higher card demand, customer acquisition, international distributor sales and FinTech demand. Improved product mix and manufacturing yields lifted gross margin. Operating expenses increased substantially—148% in Q3 and 138% year to date—contributing to lower operating margins. Nine-month GAAP net income also benefited from $38.2m of net favorable fair-value changes in earnout, warrant and derivative liabilities; these changes are not a measure of recurring operating performance.
Q3 net income attributable to Class A common stockholders was $2.8m, or $0.18 basic and diluted per share. Nine-month amounts were $15.5m, or $1.02 basic and $0.94 diluted. The company changed its EPS and income-allocation methodology effective April 1, 2022; it applied the change prospectively and disclosed that it materially affected allocation between controlling and non-controlling interests. Class A EPS for 2021 is not presented.
Balance sheet, cash flow and debt
- At September 30, cash and cash equivalents were $15.4m, down from $21.9m at December 31, 2021. Nine-month operating cash flow of $90.9m was more than offset by $90.1m of financing outflows and $7.2m of capital expenditures; cash declined $6.5m.
- Accounts receivable increased to $45.8m from $27.9m and inventory to $39.1m from $25.8m. Current liabilities were $66.9m versus $60.5m at year-end. Total stockholders’ deficit was $927.7m; redeemable non-controlling interest, classified as temporary equity, was $602.8m.
- Total debt principal was $373.1m, down from $395.0m at year-end. This included $243.1m under the credit facility and $130.0m of 7% exchangeable notes due December 2026. The $60m revolving facility had $10m drawn and $50m available, subject to covenant conditions. The credit facility matures in December 2025; the company reported compliance with its financial covenants.
- The credit facility is variable-rate debt. A $125m interest-rate swap runs through December 2025; its fair value was a $9.4m asset. The filing estimates a 100-basis-point rate change would change annual interest expense by approximately $4.0m.
- Management said cash, operating cash flows and available liquidity should meet needs, including debt repayment, for at least 12 months from filing. It also cautioned that additional liquidity, if needed, may not be available on reasonable terms or at all.
Outlook, notable items and risks
- No specific numerical revenue, profit or cash-flow guidance is provided. Management described a measured approach to Arculus investment because digital-asset market volatility and exchange difficulties have made the timing of the expected ramp-up uncertain.
- A commission dispute was resolved through binding arbitration in October 2022. The company recorded a $10.2m accrual at September 30, within the anticipated payment range, and may owe further commissions on future sales to one customer. The filing also reports related-party sales-representation commission expense of $13.4m in Q3 and $19.4m for the nine months.
- Three customers represented 76.4% of Q3 sales and 76.8% of nine-month sales. Customer concentration and dependence on key distribution relationships are material risks.
- Other cited risks include substantial debt and rising rates, LIBOR transition, economic uncertainty and inflation, supply-chain and chip availability, dependence on the primary production facility, cybersecurity and product-security risks, and uncertain regulation and commercialization of Arculus. Management said the pandemic had not significantly affected results to date, but future effects remain uncertain.
- Management concluded disclosure controls and procedures were effective as of September 30, 2022; no material change in internal control over financial reporting during the quarter was reported.
Important facts for investors to verify
- Confirm the issuer identity: the filing itself is CompoSecure, Inc., despite the request metadata naming GPGI, Inc.
- Assess whether sales growth and gross-margin gains can continue while operating expenses and customer concentration remain high.
- Separate operating performance from non-cash fair-value gains and consider the effect of the revised EPS allocation methodology.
- Review the arbitration accrual, future commission obligations and related-party arrangement disclosures.
- Monitor cash conversion, working-capital growth, debt service, covenant headroom and variable-rate exposure.
- Evaluate Arculus adoption and regulatory, partner, cybersecurity and digital-asset market risks; the filing provides no quantified Arculus outlook.